| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/17/2005 | WO2005013690A1 Medium for conservation of organs, biological tissues or living cells |
| 02/17/2005 | WO2005013680A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 02/17/2005 | WO2004087044A3 Drug target |
| 02/17/2005 | WO2004050826A3 Method of dynamically culturing embryonic stem cells |
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004020572A3 Bioreactor with expandable surface area for culturing cells |
| 02/17/2005 | WO2003104412A3 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects |
| 02/17/2005 | WO2003102156B1 Heterologous stimulus-gated ion channels and methods of using same |
| 02/17/2005 | WO2003101396A3 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039232 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/17/2005 | US20050039227 Nucleic acid encoding GAI gene of Arabidopsis thaliana |
| 02/17/2005 | US20050039224 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050038610 Apparatus and method for automated protein design |
| 02/17/2005 | US20050038492 Method for forming matrices of hardened material |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050037966 Keratinocyte growth factor-2 |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037495 Human CNS cell lines and methods of use therefor |
| 02/17/2005 | US20050037493 Protocols for making hepatocytes from embryonic stem cells |
| 02/17/2005 | US20050037492 Nutrient broth for propagation of progenitor cells for use in drug screeniing and human therapy |
| 02/17/2005 | US20050037491 Repair and regeneration of ocular tissue using postpartum-derived cells |
| 02/17/2005 | US20050037490 Medium for preparing dedifferentiated cells |
| 02/17/2005 | US20050037489 Methods of generating human cardiac cells and tissues and uses thereof |
| 02/17/2005 | US20050037488 Human pluripotent stem cell culture for use in regenerative medicine and tissue repair; tissue engineering and gene therapy |
| 02/17/2005 | US20050037469 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair |
| 02/17/2005 | US20050037467 83 human secreted proteins |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037448 C-peptide specific assay procedure |
| 02/17/2005 | US20050037434 Immunolobulin which interferes with lysosome associated membrane protein 1(LAMP-1) ligand binding for use in treatment and prevention of autoimmune diabetes |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037411 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037375 Using ligand-receptor interactions as tool to monitor effectiveness of modulators in disease treatment which act via receptor binding; drug screening and design |
| 02/17/2005 | US20050037355 Measuring intracellular adenosine triphosphate and/or gene expression in transgenic cell via monitoring luciferin bioluminescent signals; genetiic engineering and reporter molecules |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037334 Method of determining sperm capacitation |
| 02/17/2005 | US20050037330 Composition for maintaining organ and cell viability |
| 02/17/2005 | US20050037029 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037002 Synergistic mixture of a blocking agent of an inhibitory receptor or stimulant of an activating receptor of natural killer cells and an antibody that can be bound by the CD16 antigen; efficiency is enhanced through the increase of the antibody-dependent cellular cytoxicity mechanism |
| 02/17/2005 | US20050036995 Immunogens; tumor antigens; kits |
| 02/17/2005 | US20050036994 Compounds and methods for downregulating the effects of TGF-beta |
| 02/17/2005 | US20050036993 Immune activation by double-stranded polynucleotides |
| 02/17/2005 | US20050036992 Novel use of liver X receptor agonists |
| 02/17/2005 | US20050036991 For preventing and/or treating transplant/xenotransplant rejection; interleukin-1B converting enzyme inhibitors |
| 02/17/2005 | US20050036980 cell adhesion promoting (CAP) peptide combinations that promote cell attachment or cell adhesion to culture surfaces that are otherwise cell adhesion resistant CAR); peptides when coupled to a CAR layer such as hyaluronic acid that has been created on a polymer surface, promote cell growth |
| 02/17/2005 | DE10333863A1 Bioartifizielles, primär vaskularisiertes Testgewebe für pharmakologische Testverfahren, Verfahren zu dessen Herstellung und Testverfahren unter dessen Verwendung sowie Bioreaktor zur Durchführung der Verfahren Bioartificial primarily vascularized tissue test for pharmacological test procedures, to processes for its preparation and test method, as well as its use bioreactor for carrying out the method |
| 02/17/2005 | DE10331291A1 Varianten der 3-Phosphoglyceratdehydrogenase mit reduzierter Hemmung durch L-Serin und dafür codierende Gene Variants of the 3-phosphoglycerate dehydrogenase with reduced inhibition by L-serine, and genes coding therefor |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2537555A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | CA2536656A1 Medium for conservation of organs, biological tissues or living cells |
| 02/17/2005 | CA2535517A1 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | CA2534973A1 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | CA2534659A1 A variant cell surface molecule associated with cancer |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | CA2534591A1 Method for purifying mesenchymal stem cells |
| 02/17/2005 | CA2534352A1 Methods of protein production in yeast |
| 02/17/2005 | CA2532444A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | CA2532312A1 Process for the production of fine chemicals in plants |
| 02/17/2005 | CA2530482A1 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/16/2005 | EP1507007A1 Cell cycle related proteins |
| 02/16/2005 | EP1507005A2 Antisense modulation of BCL-X expression |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1507000A2 A thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 02/16/2005 | EP1506998A1 An in vitro tumor angiogenesis model |
| 02/16/2005 | EP1506997A1 Method of generating neural stem cells |
| 02/16/2005 | EP1506318A2 Methods and compositions for regulation and manipulation of steroidogenesis |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506294A1 Hydantoin racemase |
| 02/16/2005 | EP1506293A2 Microbial conversion of glucose to para-hydroxystyrene |
| 02/16/2005 | EP1506291A2 Novel phospholipases and uses thereof |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP1506284A2 Cell culture device |
| 02/16/2005 | EP1506235A1 Method for producing monoclonal antibodies |
| 02/16/2005 | EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 02/16/2005 | EP1506027A1 Cell delivery fluid for prevention of cell settling in delivery system |
| 02/16/2005 | EP1506013A1 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1505873A2 Universal chimera bank |
| 02/16/2005 | EP1505871A2 Preservation of rna and morphology in cells and tissues |
| 02/16/2005 | EP1432811A4 Cell separation matrix |
| 02/16/2005 | EP1414957A4 Vascular tissue preferred promoters |
| 02/16/2005 | EP1373473A4 Gene targeting methods and vectors |
| 02/16/2005 | EP1161548B1 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/16/2005 | EP1093524B1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 02/16/2005 | EP0858502B1 Normal neural epithelial precursor cells |
| 02/16/2005 | EP0853672B1 DNA SEQUENCES CODING FOR A CINNAMOYL CoA REDUCTASE, AND APPLICATIONS THEREOF IN THE CONTROL OF LIGNIN CONTENTS IN PLANTS |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582341A Method of isolating cells and uses thereof |
| 02/16/2005 | CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582335A Rice transposon genes |